Valuation: Hologic, Inc.

Market Cap 16.97B 14.54B 13.6B 12.45B 23.36B 1,624B 23.67B 161B 62.66B 816B 63.72B 62.33B 2,698B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 14.9B 13.94B 12.76B 23.94B 1,664B 24.26B 165B 64.22B 836B 65.3B 63.88B 2,765B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
6 months+0.77%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 63.19
Extreme 63.1923
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap.
7/4/26 Issuer sale

Director

23,407 0.0105%
27/2/26 Tax

General Counsel

185 0.0001%
26/2/26 Free

Director

3,190 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+13.16%+1.04% 16.97B
+0.27%+6.97%+30.08%+18.23% 233B
+1.36%+8.10%+7.33%-12.52% 154B
+1.16%-3.98%-19.38%+32.14% 134B
+2.03%-2.82%-52.12%-0.10% 73B
-0.04%-1.98%+10.63%+17.63% 51.75B
+0.98%+2.26%-15.88%-11.61% 52.24B
+1.73%+7.05%+35.72%+33.77% 44.91B
+1.49%-0.36%+41.41%+53.72% 40.35B
+1.03%+1.53%+2.28%+8.48% 33.8B
Average +1.09%+1.64%+5.32%+14.08% 83.34B
Weighted average by Cap. +1.00%+2.95%+6.03%+13.08%

Financials

2024 2025
Net sales 4.03B 3.45B 3.23B 2.96B 5.55B 386B 5.62B 38.16B 14.88B 194B 15.13B 14.8B 641B 4.1B 3.51B 3.29B 3.01B 5.65B 392B 5.72B 38.83B 15.14B 197B 15.4B 15.06B 652B
Net income 790M 676M 633M 579M 1.09B 75.54B 1.1B 7.48B 2.92B 37.95B 2.96B 2.9B 126B 566M 485M 453M 415M 779M 54.13B 789M 5.36B 2.09B 27.19B 2.12B 2.08B 89.93B
Net Debt 321M 275M 258M 236M 442M 30.74B 448M 3.04B 1.19B 15.44B 1.21B 1.18B 51.08B 421M 361M 337M 309M 580M 40.27B 587M 3.99B 1.55B 20.23B 1.58B 1.55B 66.91B
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. HOLX Stock